Systematic Review of Pharmacologic Treatment for Migraine Prevention in Adults: Report of the AAN Guidelines Subcommittee and the American Headache Society.

This systematic review examined medications that prevent migraines in adults. It aimed to update guidelines for treating migraine based on recent evidence. A panel of experts reviewed numerous studies on migraine treatments. They focused on randomized controlled trials for both episodic and chronic migraines. Researchers searched databases like MEDLINE and ClinicalTrials.gov for relevant studies. The review assessed how well these medications reduced headache days and improved quality of life. They calculated various statistical measures to evaluate treatment effectiveness. The findings will help shape new guidelines for clinicians. These guidelines will provide clearer recommendations for managing migraines with medications. Overall, this research is crucial for improving migraine care. It highlights the importance of evidence-based approaches in selecting preventive treatments. The hope is that patients will benefit from more effective and tailored migraine prevention strategies based on these findings. Clinical relevance: This research provides updated guidelines for clinicians on effective migraine prevention treatments, enhancing patient care and outcomes.